Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Omeros Corporation
About OMER
Omeros Corporation is a clinical-stage biopharmaceutical company. The Company focuses on discovering, developing, and commercializing first-in-class small-molecule and protein therapeutics for both large-market and orphan indications, with a particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. Its clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program. Its commercial product, YARTEMLEA, is the approved inhibitor of the lectin pathway of complement. YARTEMLEA is used for the treatment of TA-TMA in adults and in children ages two years and older. YARTEMLEA selectively inhibits MASP-2, blocking pathway activation while preserving classical and alternative complement pathway functions.
Find out what a historical investment in Omeros Corporation would be worth today using our OMER stock calculator.
Market Capitalisation
$712.90M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.54M
High today
$10.04
Low today
$9.55
Open price
$9.86
52-week high
$17.65
52-week low
$2.95
Ready to start your investing journey with Stake?
Open an accountHow do I buy OMER shares in Australia?
Buying OMER shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Omeros Corporation in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in OMER
What is the ticker symbol of Omeros Corporation?
The ticker symbol for Omeros Corporation is OMER.
How much is one share of OMER?
One share of OMER is valued at $9.92 as of 10 June 2026.
What is the market capitalisation of Omeros Corporation OMER?
As of 10 June 2026 Omeros Corporation has a market cap of $712.90M.
What is the P/E ratio of OMER?
The Price to Earnings ratio of OMER is 10.56.
What is the Earnings Per Share of OMER?
The Earnings Per Share of OMER is $0.93.
What is the 52-week high for Omeros Corporation stock?
The Omeros Corporation 52-week high stock price is $17.65.
What is the 52-week low for Omeros Corporation stock?
The Omeros Corporation 52-week low stock price is $2.95.
Can I buy OMER shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy OMER shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in OMER on Stake
- Buy OMER from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of OMER from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
OMER related stocks